Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin prior to vestibular schwannoma surgery
NCT02415257Phase 4Withdrawn
- Sponsor
- Lund University
- Start
- Apr 2015
- Primary completion
- Sep 2020
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of gentamicin in vestibular schwannoma (VS), sponsored by Lund University. Planned start Apr 2015; status: withdrawn.
02
Drugs
gentamicin
03
Conditions
vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT02415257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415257.